Verition Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
63,800
+50,200
+369% +$1.34M 0.01% 1080
2025
Q4
$339K Sell
13,600
-66,400
-83% -$1.67M ﹤0.01% 2944
2025
Q3
$2.04M Buy
80,000
+22,900
+40% +$565K 0.01% 1961
2025
Q2
$1.38M Hold
57,100
0.01% 2222
2025
Q1
$1.45M Buy
57,100
+41,900
+276% +$1.1M 0.01% 1820
2024
Q4
$403K Sell
15,200
-15,300
-50% -$415K ﹤0.01% 2603
2024
Q3
$883K Sell
30,500
-104,000
-77% -$3.03M ﹤0.01% 1966
2024
Q2
$3.76M Buy
134,500
+116,600
+651% +$3.21M 0.02% 893
2024
Q1
$497K Sell
17,900
-27,200
-60% -$755K ﹤0.01% 2008
2023
Q4
$1.3M Sell
45,100
-57,300
-56% -$1.73M 0.01% 1046
2023
Q3
$3.4M Buy
102,400
+66,300
+184% +$2.34M 0.04% 575
2023
Q2
$1.32M Buy
+36,100
New +$1.41M 0.02% 833
2023
Q1
Sell
-16,700
Closed -$856K 2466
2022
Q4
$856K Sell
16,700
-20,900
-56% -$1M 0.01% 993
2022
Q3
$1.65M Buy
+37,600
New +$1.83M 0.02% 1048
2022
Q2
Sell
-63,100
Closed -$3.27M 2891
2022
Q1
$3.27M Buy
63,100
+17,000
+37% +$882K 0.04% 624
2021
Q4
$2.72M Buy
+46,100
New +$2.28M 0.02% 684

Other funds holding PFE

Verition Fund Management's PFE Position: Q1 2026 in Review

Verition Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 248,837 shares — an estimated $6.62M sold.

Verition Fund Management first reported a position in PFE in Q3 2013 and held it in 37 quarters. The position peaked at $9.32M in Q3 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Verition Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 248,837 Pfizer shares in Q1 2026, an estimated $6.62M.
  • Verition Fund Management first reported a position in Pfizer in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Pfizer position peaked at $9.32M in Q3 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.